Variant report
Variant | rs10845161 |
---|---|
Chromosome Location | chr12:10705835-10705836 |
allele | C/T |
Outlinks | Ensembl   UCSC |
- TF binding region (count:14)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:14 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | POLR2A | chr12:10705714-10706217 | GM12891 | blood: | n/a | n/a |
2 | NFIC | chr12:10705349-10706534 | GM12878 | blood: | n/a | n/a |
3 | TAF1 | chr12:10705818-10706091 | GM12891 | blood: | n/a | n/a |
4 | NFATC1 | chr12:10705779-10706431 | GM12878 | blood: | n/a | n/a |
5 | POLR2A | chr12:10705810-10706173 | GM12878 | blood: | n/a | n/a |
6 | TAF1 | chr12:10705827-10706095 | GM12891 | blood: | n/a | n/a |
7 | STAT5A | chr12:10705824-10706255 | GM12878 | blood: | n/a | n/a |
8 | PML | chr12:10705485-10706439 | GM12878 | blood: | n/a | n/a |
9 | FOXM1 | chr12:10705467-10706224 | GM12878 | blood: | n/a | n/a |
10 | TAF1 | chr12:10705791-10706088 | GM12878 | blood: | n/a | n/a |
11 | RUNX3 | chr12:10705709-10706191 | GM12878 | blood: | n/a | n/a |
12 | CEBPB | chr12:10705717-10706316 | GM12878 | blood: | n/a | n/a |
13 | MTA3 | chr12:10705764-10706252 | GM12878 | blood: | n/a | n/a |
14 | POLR2A | chr12:10705746-10706215 | GM12891 | blood: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
SLC25A39P2 | TF binding region |
ENSG00000256039 | TF binding region |
rs_ID | r2[population] |
---|---|
rs10734838 | 0.83[ASN][1000 genomes] |
rs10743910 | 0.83[ASN][1000 genomes] |
rs10772298 | 0.87[AFR][1000 genomes];0.81[ASN][1000 genomes] |
rs10772312 | 0.84[AFR][1000 genomes];0.90[AMR][1000 genomes];0.80[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs10772315 | 0.94[AFR][1000 genomes];0.98[AMR][1000 genomes];1.00[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs10772316 | 0.89[AMR][1000 genomes];0.93[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs10772317 | 0.84[ASN][1000 genomes] |
rs10772319 | 0.83[ASN][1000 genomes] |
rs10772321 | 0.83[ASN][1000 genomes] |
rs10772323 | 0.83[ASN][1000 genomes] |
rs10772324 | 0.84[ASN][1000 genomes] |
rs10772325 | 0.82[ASN][1000 genomes] |
rs10772326 | 0.83[ASN][1000 genomes] |
rs10772327 | 0.83[ASN][1000 genomes] |
rs10772329 | 0.85[AMR][1000 genomes];0.91[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs10845163 | 0.81[ASN][1000 genomes] |
rs10845164 | 0.82[ASN][1000 genomes] |
rs10845165 | 0.84[ASN][1000 genomes] |
rs10845166 | 0.84[ASN][1000 genomes] |
rs10845172 | 0.83[ASN][1000 genomes] |
rs10845174 | 0.81[ASN][1000 genomes] |
rs10845175 | 0.85[CHB][hapmap];0.90[JPT][hapmap];0.88[YRI][hapmap];0.81[AMR][1000 genomes];0.88[ASN][1000 genomes] |
rs11053857 | 1.00[CEU][hapmap];1.00[CHB][hapmap];0.95[JPT][hapmap];1.00[YRI][hapmap];0.90[AFR][1000 genomes];0.98[AMR][1000 genomes];1.00[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs11053859 | 0.81[AFR][1000 genomes];0.89[AMR][1000 genomes];0.96[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs11053865 | 0.88[AMR][1000 genomes];0.93[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs11053869 | 0.83[ASN][1000 genomes] |
rs11053870 | 0.83[ASN][1000 genomes] |
rs11053871 | 0.88[AMR][1000 genomes];0.92[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs11611202 | 0.94[CEU][hapmap];0.90[CHB][hapmap];0.95[JPT][hapmap];0.88[YRI][hapmap];0.88[AMR][1000 genomes];0.91[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs12423957 | 0.95[CHB][hapmap];0.91[JPT][hapmap];0.81[AMR][1000 genomes];0.90[ASN][1000 genomes] |
rs1915322 | 0.82[ASN][1000 genomes] |
rs1915323 | 0.83[ASN][1000 genomes] |
rs2002156 | 0.90[AFR][1000 genomes];0.91[AMR][1000 genomes];0.96[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs2002157 | 0.95[CHB][hapmap];0.90[JPT][hapmap];1.00[YRI][hapmap];0.90[AFR][1000 genomes];0.91[AMR][1000 genomes];0.96[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs2125092 | 0.84[ASN][1000 genomes] |
rs2125094 | 0.82[ASN][1000 genomes] |
rs2125095 | 0.84[ASN][1000 genomes] |
rs2168750 | 0.83[ASN][1000 genomes] |
rs2417745 | 0.81[JPT][hapmap] |
rs2417746 | 0.85[JPT][hapmap];0.84[ASN][1000 genomes] |
rs2417747 | 0.83[ASN][1000 genomes] |
rs2417748 | 0.84[ASN][1000 genomes] |
rs2607883 | 0.85[JPT][hapmap] |
rs2607888 | 0.85[JPT][hapmap] |
rs2607891 | 0.80[JPT][hapmap] |
rs2607892 | 0.80[JPT][hapmap] |
rs2607898 | 0.85[JPT][hapmap] |
rs2682476 | 0.80[JPT][hapmap] |
rs28403396 | 0.87[AMR][1000 genomes];0.89[EUR][1000 genomes];0.85[ASN][1000 genomes] |
rs28701155 | 0.85[AMR][1000 genomes];0.91[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs3816567 | 0.94[CEU][hapmap];0.90[CHB][hapmap];0.90[JPT][hapmap];0.88[YRI][hapmap];0.87[AMR][1000 genomes];0.91[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs3867478 | 0.84[ASN][1000 genomes] |
rs3983544 | 0.83[ASN][1000 genomes] |
rs3983545 | 0.83[ASN][1000 genomes] |
rs3983546 | 0.83[ASN][1000 genomes] |
rs3983547 | 0.81[ASN][1000 genomes] |
rs4237928 | 0.90[AFR][1000 genomes];0.91[AMR][1000 genomes];0.97[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs4476009 | 0.81[AFR][1000 genomes];0.91[AMR][1000 genomes];0.96[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs4763528 | 0.84[ASN][1000 genomes] |
rs4763531 | 0.84[ASN][1000 genomes] |
rs4763532 | 0.84[ASN][1000 genomes] |
rs4763547 | 0.87[AMR][1000 genomes];0.99[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs4763548 | 0.87[AMR][1000 genomes];0.99[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs4763550 | 0.82[ASN][1000 genomes] |
rs4763551 | 0.82[ASN][1000 genomes] |
rs4763553 | 0.82[ASN][1000 genomes] |
rs4763555 | 0.89[AMR][1000 genomes];0.93[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs4763559 | 0.83[ASN][1000 genomes] |
rs55837119 | 0.93[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs58917785 | 0.88[AMR][1000 genomes];0.93[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs60367665 | 0.88[AMR][1000 genomes];0.91[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs61913124 | 0.81[AMR][1000 genomes];0.91[ASN][1000 genomes] |
rs6488306 | 0.85[JPT][hapmap] |
rs6488307 | 0.83[ASN][1000 genomes] |
rs7134658 | 0.83[ASN][1000 genomes] |
rs7134908 | 0.83[ASN][1000 genomes] |
rs7136964 | 0.82[ASN][1000 genomes] |
rs7137465 | 0.81[ASN][1000 genomes] |
rs7306285 | 0.83[ASN][1000 genomes] |
rs7306724 | 0.84[ASN][1000 genomes] |
rs7311860 | 0.82[ASN][1000 genomes] |
rs7965052 | 0.82[ASN][1000 genomes] |
rs7971934 | 0.80[ASN][1000 genomes] |
rs7978850 | 0.94[CEU][hapmap];0.95[CHB][hapmap];0.90[JPT][hapmap];0.88[YRI][hapmap];0.88[AMR][1000 genomes];0.93[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs7980411 | 0.83[ASN][1000 genomes] |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | nsv898766 | chr12:10537269-10722585 | Enhancers Active TSS Weak transcription Bivalent Enhancer Flanking Active TSS ZNF genes & repeats Strong transcription Bivalent/Poised TSS Genic enhancers Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 22 gene(s) | inside rSNPs | diseases |
2 | nsv557459 | chr12:10560591-10729821 | Genic enhancers Enhancers ZNF genes & repeats Weak transcription Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Strong transcription Bivalent Enhancer Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 22 gene(s) | inside rSNPs | diseases |
3 | nsv898772 | chr12:10622047-10722585 | Flanking Active TSS Enhancers ZNF genes & repeats Weak transcription Active TSS Bivalent/Poised TSS Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNA | 10 gene(s) | inside rSNPs | diseases |
4 | nsv557479 | chr12:10644663-10729821 | Weak transcription Enhancers Active TSS Flanking Active TSS ZNF genes & repeats Bivalent Enhancer Bivalent/Poised TSS Genic enhancers | TF binding regionCpG islandChromatin interactive regionlncRNA | 12 gene(s) | inside rSNPs | diseases |
5 | nsv898773 | chr12:10660850-10722585 | Enhancers Active TSS Weak transcription Flanking Active TSS ZNF genes & repeats Bivalent Enhancer Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 9 gene(s) | inside rSNPs | diseases |
6 | nsv898774 | chr12:10666025-10722585 | Enhancers Flanking Active TSS ZNF genes & repeats Weak transcription Active TSS Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNA | 9 gene(s) | inside rSNPs | diseases |
7 | nsv898775 | chr12:10668694-10735786 | Weak transcription Active TSS ZNF genes & repeats Flanking Active TSS Enhancers Strong transcription Bivalent Enhancer Genic enhancers | TF binding regionCpG islandChromatin interactive regionlncRNA | 11 gene(s) | inside rSNPs | diseases |
8 | nsv1039120 | chr12:10675930-10755446 | Weak transcription Active TSS Genic enhancers Enhancers Strong transcription ZNF genes & repeats Flanking Active TSS Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNA | 13 gene(s) | inside rSNPs | diseases |
9 | nsv832329 | chr12:10677094-10845946 | Strong transcription Enhancers Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Genic enhancers ZNF genes & repeats Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNA | 26 gene(s) | inside rSNPs | diseases |
No data |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:10705400-10706000 | Enhancers | Primary T helper naive cells from peripheral blood | blood |
2 | chr12:10705600-10706200 | Flanking Active TSS | Primary T killer naive cells fromperipheralblood | blood |
3 | chr12:10705800-10706000 | Enhancers | Primary Natural Killer cells fromperipheralblood | blood |
4 | chr12:10705800-10706000 | Enhancers | Fetal Thymus | thymus |
5 | chr12:10705800-10707000 | Weak transcription | Primary T killer memory cells from peripheral blood | blood |